Paper3892003
A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.
Goodford PJ. J Med Chem, 1985. Cited by 1,919 papers, by iCite.
Cite this record
ConductScience Library. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. Papers, record 3892003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3892003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Binding Sites | Major topic |
| Proteins | Major topic |
| Chemical Phenomena | |
| Chemistry, Physical | |
| Electrochemistry | |
| Escherichia coli | |
| Hydrogen Bonding | |
| Macromolecular Substances | |
| Methotrexate | |
| Nitrogen | |
| Oxygen | |
| Phospholipases A | |
| Tetrahydrofolate Dehydrogenase | |
| Trimethoprim | |
| Water | |
| X-Ray Diffraction |
Source PubMed
Cited by525
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,919 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42912897 | Artificial Intelligence in the Discovery and Design of Ionic Liquids for Thermal Energy Applications. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/42912897 | PubMed |
| 42792059 | Cinnamomum zeylanicum, Origanum vulgare, and Thymus vulgaris Essential Oils in Cystitis: An Alternative/Complementary Perspective. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42792059 | PubMed |
| 42655947 | Mixture-Quantitative Structure-Property Relationship Approaches for Jet Fuel-Component Blends: A Review. | Mol Inform | 2026 | https://conductscience.org/library/papers/42655947 | PubMed |
| 42622265 | Three-Dimensional Descriptions of π/π, CH/π, and Halogen/π Interactions Formed between Phenyl Substructures. | J Phys Chem B | 2026 | https://conductscience.org/library/papers/42622265 | PubMed |
| 42618991 | Ligand‑Based Virtual Screening Discovery of Thienopyrimidinone Derivatives as Allosteric nSMase2 Modulators and Antivirals Against West Nile Virus. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42618991 | PubMed |
| 42495344 | Ensemble Docking and Molecular Dynamics Indicate Dynamic Modulation of hnRNPA1 UP1 Interdomain Behavior by Natural Products. | ACS Omega | 2026 | https://conductscience.org/library/papers/42495344 | PubMed |
| 42121291 | GRIPHIN: grids of pharmacophore interaction fields for affinity prediction. | J Cheminform | 2026 | https://conductscience.org/library/papers/42121291 | PubMed |
| 42052800 | Gaining insights into MmpL3: combining structural and computational approaches to unlock transport and inhibitor-binding mechanisms. | Acta Crystallogr D Struct Biol | 2026 | https://conductscience.org/library/papers/42052800 | PubMed |
| 41652164 | Computational Ligand-Binding Site Prediction. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/41652164 | PubMed |
| 41646389 | Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoids. | Res Sq | 2026 | https://conductscience.org/library/papers/41646389 | PubMed |
| 41584329 | Computational approaches to druggable site identification: Current status and future perspective. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41584329 | PubMed |
| 41292358 | GridFF: Efficient Simulation of Organic Molecules on Rigid Substrates. | J Chem Theory Comput | 2025 | https://conductscience.org/library/papers/41292358 | PubMed |
| 41283657 | Boosting Drug Discovery: Expanding the Applicability of Fragment Dissolved Molecular Dynamics to Accelerate Binding Mode Elucidation. | J Chem Inf Model | 2025 | https://conductscience.org/library/papers/41283657 | PubMed |
| 41075089 | Hands-On Docking with Molegro Virtual Docker. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/41075089 | PubMed |
| 41012299 | Integrating Computational and Experimental Methods for the Rational Ecodesign and Synthesis of Functionalized Safe and Sustainable Biobased Oligoesters. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/41012299 | PubMed |
| 40765306 | Arrestins as Possible Drug Targets. | Biomol Ther (Seoul) | 2025 | https://conductscience.org/library/papers/40765306 | PubMed |
| 40732248 | Target Mapping in Cancer: Ligandable Protein Pockets on 3D OncoPPI Networks. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40732248 | PubMed |
| 40576287 | Bombyx Mori Silk Fibroin as a Sustainable Organocatalyst for Diastereoselective Michael Additions. | ChemSusChem | 2025 | https://conductscience.org/library/papers/40576287 | PubMed |
| 40517145 | Structural adaptability of SARS-CoV-2 Nsp1 with the host network. | Eur Biophys J | 2026 | https://conductscience.org/library/papers/40517145 | PubMed |
| 40365658 | Synthesis, Antimycobacterial Activity, and Computational Insight of Novel 1,4-Benzoxazin-2-one Derivatives as Promising Candidates against Multidrug-Resistant Mycobacterium Tuberculosis. | ChemMedChem | 2025 | https://conductscience.org/library/papers/40365658 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3892003
GET https://conductscience.org/api/papers/v1/3892003/cited_by?page=2